Prothrombotic gene variants as risk factors of acute myocardial infarction in young women

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Tomaiuolo, Rossella ^a,b   Bellia, Chiara ^c   Caruso, Antonietta ^c   Di Fiore, Rosanna ^b   Quaranta, Sandro ^b   Noto, Davide ^c   Cefalù, Angelo B ^c   Di Micco, Pierpaolo ^d   Zarrilli, Federica ^e   Castaldo, Giuseppe ^a,b   Averna, Maurizio R ^c   Ciaccio, Marcello ^c  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d Ospedale Fatebenefratelli di Napoli   (Italy)

^e UNIVERSITY OF MOLISE   (Italy)

Author keywords

AMI; Gender; Gene variants; Genetic predisposition; Mutations; Prothrombotic variants; Young AMI

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; FOLIC ACID; HOMOCYSTEINE; PROTHROMBIN;

ACUTE HEART INFARCTION; ADULT; AGE; ARTICLE; BETA FIBRINOGEN GENE; CONTROLLED STUDY; FACTOR V LEIDEN GENE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MTHFR GENE; PROTHROMBIN GENE; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

ADULT; AGED; FACTOR V; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; MALE; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTHROMBIN; RISK FACTORS; THROMBOSIS;

EID: 84869209728     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-235     Document Type: Article

References (21)

1. Choudhury L, Marsh JD. Myocardial infarction in young patients. Am J Med 1999, 107:254-261. 10.1016/S0002-9343(99)00218-1, 10492319.
2. Doughty M, Mehta R, Bruckman D, Das S, Karavite D, Tsai T, Eagle K. Acute myocardial infarction in the young-The University of Michigan experience. Am Heart J 2002, 143:56-62. 10.1067/mhj.2002.120300, 11773912.
3. Fournier JA, Cabezón S, Cayuela A, Ballesteros SM, Cortacero JA, Díaz De La Llera LS. Long-term prognosis of patients having acute myocardial infarction when
4. Marenberg ME, Risch N, Berkman LF, Floderus B, De Faire U. Genetic susceptibility to death from coronary heart disease in a study of twuins. N Engl J Med 1994, 330:1041-1046. 10.1056/NEJM199404143301503, 8127331.
5. Bafunno V, Margaglione M. Genetic basis of thrombosis. Clin Chem Lab Med 2010, 48:S41-S51.
6. Kyrle PA, Rosendaal FR, Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet 2010, 376:2032-2039. 10.1016/S0140-6736(10)60962-2, 21131039.
7. Di Micco P, Di Fiore R, Niglio A, Quaranta S, Angiolillo A, Cardillo G, Castaldo G. Different outcome of six homozygotes for prothrombin A20210A gene variant. J Transl Med 2008, 15:36.
8. Kathiresan S, Yang Q, Larson MG, Camargo AL, Tofler GH, Hirschhorn JN, Gabriel SB, O'Donnell CJ. Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk. Arterioscler Thromb Vasc Biol 2006, 26:1405-1412. 10.1161/01.ATV.0000222011.13026.25, 16614319.
9. Zheng Y, Liu EHC, Higgins JPT, Keavney BD, Lowe GDO, Collins R, Danesh J. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66155 cases and 91307 controls. Lancet 2006, 367:651-658. 10.1016/S0140-6736(06)68263-9, 16503463.
10. Mannucci PM, Asselta R, Duga S, Guella I, Spreafico M, Lotta L, Merlini PA, Peyvandi F, Kathiresan S, Ardissino D. The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature disease. J Thromb Haemost 2010, 8:2116-2121. 10.1111/j.1538-7836.2010.03982.x, 20626623.
11. Atherosclerosis, Thrombosis and Vascular Biology Italian Study Group No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 2003, 107:1117-1122. 10.1161/01.CIR.0000051465.94572.D0, 12615788, Atherosclerosis, Thrombosis and Vascular Biology Italian Study Group.
12. Yamada Y, Ichihara S, Nishida T. Molecular genetics of myocardial infarction. Genomic Med 2008, 2:7-22. 10.1007/s11568-008-9025-x, 2518661, 18704761.
13. Ioannidis JPA, Trikalinos TA, Nizani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003, 361:567-571. 10.1016/S0140-6736(03)12516-0, 12598142.
14. Thygesen K, Alpert JS, White HD. On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal Definition of Myocardial Infarction. Circulation 2007, 116:2634-2653. 10.1161/CIRCULATIONAHA.107.187397, 17951284.
15. Scudiero O, Nardone G, Omodei D, Tatangelo F, Vitale DF, Salvatore F, Castaldo G. A mannose-binding lectin defective haplotype is a risk factor for gastric cancer. Clin Chem 2006, 52:1625-1627. 10.1373/clinchem.2006.071696, 16873315.
16. Tomaiuolo R, Ruocco A, Salapete C, Carru C, Baggio G, Franceschi C, Zinellu A, Vaupel J, Bellia C, Lo Sasso B, Ciaccio M, Castaldo G, Deiana L. Activity of mannose-binding lectin in centenarians. Aging Cell 2012, 11:394-400. 10.1111/j.1474-9726.2012.00793.x, 22239660.
17. Bellia C, Tomaiuolo R, Caruso A, Sasso BL, Zarrilli F, Carru C, Deiana M, Zinellu A, Pinna S, Castaldo G, Deiana L, Ciaccio M. Fetuin-A serum levels are not correlated to kidney function in long-lived subjects. Clin Biochem 2012, 45:637-640. 10.1016/j.clinbiochem.2012.02.024, 22425942.
18. Boekholdt SM, Bijsterveld NR, Moons AHM, Levi M, Büller HR, Peters RJG. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction. Circulation 2001, 104:3063-3068. 10.1161/hc5001.100793, 11748101.
19. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, Shindo T, Minamino T, Ohno M, Yamaoki K, Ogasawara K, Aizawa T, Suzuki S, Yazaki Y. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997, 95:2032-2036. 10.1161/01.CIR.95.8.2032, 9133512.
20. Meleady R, Ueland PM, Blom H, Whitehead AS, Refsum H, Daly LE, Vollset SE, Donohue C, Giesendorf B, Graham IM, Ulvik A, Zhang Y, Bjorke Monsen AL, . EC Concerted Action Project: Homocysteine and Vascular Disease Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project. Am J Clin Nutr 2003, 77:63-70. EC Concerted Action Project: Homocysteine and Vascular Disease.
21. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG, . MTHFR Studies Collaboration Group MTHFR 677C>T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002, 288:2023-2031. 10.1001/jama.288.16.2023, 12387655, MTHFR Studies Collaboration Group.